DemitriPapolosMD

Child & Adolescent Psychiatry, Neuropsychiatry

Director of Research Juvenile Bipolar Research Foundation

Dr. Papolos is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

New York Presbyterian Hospital (Columbia Campus)/New York State Psychiatric InstituteResidency, Psychiatry, 1977 - 1980
New York Medical College (Metropolitan)Residency, Internal Medicine, 1976 - 1977
New York Medical CollegeClass of 1976

PubMed

1382 citations
Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders.
Herbert M. Lachman, Demitri F. Papolos, Takuya Saito, Yue Min Yu, Carol L. Szumlanski
Pharmacogenetics. 1996-06-01
45 citations
Clinical experience using intranasal ketamine in the treatment of pediatric bipolar disorder/fear of harm phenotype.
Demitri F. Papolos, Martin H. Teicher, Gianni L. Faedda, Patricia Murphy, Steven Mattis
Journal of Affective Disorders. 2013-05-01
95 citations
Increase in GSK3β gene copy number variation in bipolar disorder
Herbert M. Lachman, Erika Pedrosa, Oriana A. Petruolo, Melissa S. Cockerham, Alexander Papolos
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics. 2007-04-05

FDA Approves Anti-Depressant Nasal Spray Based on Ketamine Party DrugNovember 30th, 2019
FDA Approves Esketamine Nasal Spray for Hard-to-Treat DepressionMarch 6th, 2019
From Chaos to Calm: A Life Changed by KetamineJune 8th, 2018
Join now to see all